{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:13:46Z","timestamp":1792167226233,"version":"4.4.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T00:00:00Z","timestamp":1625702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82000980"],"award-info":[{"award-number":["82000980"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.apsb.2021.07.002","type":"journal-article","created":{"date-parts":[[2021,7,10]],"date-time":"2021-07-10T11:13:50Z","timestamp":1625915630000},"page":"167-181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Astaxanthine attenuates cisplatin ototoxicity in\u00a0vitro and protects against cisplatin-induced hearing loss in\u00a0vivo"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1824-8827","authenticated-orcid":false,"given":"Benyu","family":"Nan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zirui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanglun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huawei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinsheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2021.07.002_bib1","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1038\/s41467-019-11712-w","article-title":"PKHD1L1 is a coat protein of hair-cell stereocilia and is required for normal hearing","volume":"10","author":"Wu","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2021.07.002_bib2","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nrd4533","article-title":"New treatment options for hearing loss","volume":"14","author":"Muller","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.apsb.2021.07.002_bib3","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.tips.2013.05.006","article-title":"Understanding platinum-induced ototoxicity","volume":"34","author":"Langer","year":"2013","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.apsb.2021.07.002_bib4","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1200\/JCO.2016.66.8822","article-title":"Comprehensive audiometric analysis of hearing impairment and tinnitus after cisplatin-based chemotherapy in survivors of adult-onset cancer","volume":"34","author":"Frisina","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.apsb.2021.07.002_bib5","doi-asserted-by":"crossref","first-page":"8588","DOI":"10.1200\/JCO.2004.00.5355","article-title":"Ototoxicity in children receiving platinum chemotherapy: underestimating a commonly occurring toxicity that may influence academic and social development","volume":"23","author":"Knight","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.apsb.2021.07.002_bib6","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1080\/14992027.2017.1355570","article-title":"Ototoxicity monitoring in children treated with platinum chemotherapy","volume":"57","author":"Brooks","year":"2018","journal-title":"Int J Audiol"},{"key":"10.1016\/j.apsb.2021.07.002_bib7","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0196-0709(86)80050-3","article-title":"Cisplatin: evaluation of its ototoxic potential","volume":"7","author":"Anniko","year":"1986","journal-title":"Am J Otolaryngol"},{"key":"10.1016\/j.apsb.2021.07.002_bib8","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.heares.2005.03.023","article-title":"The cochlear targets of cisplatin: an electrophysiological and morphological time-sequence study","volume":"205","author":"van Ruijven","year":"2005","journal-title":"Hear Res"},{"key":"10.1016\/j.apsb.2021.07.002_bib9","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1038\/s41467-017-01837-1","article-title":"Cisplatin is retained in the cochlea indefinitely following chemotherapy","volume":"8","author":"Breglio","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2021.07.002_bib10","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.2353\/ajpath.2010.090610","article-title":"Organic cation transporter 2 mediates cisplatin-induced oto- and nephrotoxicity and is a target for protective interventions","volume":"176","author":"Ciarimboli","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.apsb.2021.07.002_bib11","doi-asserted-by":"crossref","first-page":"9500","DOI":"10.1523\/JNEUROSCI.1544-10.2010","article-title":"Role of the copper transporter, CTR1, in platinum-induced ototoxicity","volume":"30","author":"More","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.apsb.2021.07.002_bib12","doi-asserted-by":"crossref","first-page":"4405","DOI":"10.1523\/JNEUROSCI.3940-12.2013","article-title":"Functional mechanotransduction is required for cisplatin-induced hair cell death in the zebrafish lateral line","volume":"33","author":"Thomas","year":"2013","journal-title":"J Neurosci"},{"key":"10.1016\/j.apsb.2021.07.002_bib13","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3389\/fncel.2017.00338","article-title":"Mechanisms of cisplatin-induced ototoxicity and otoprotection","volume":"11","author":"Sheth","year":"2017","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.apsb.2021.07.002_bib14","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.molmed.2019.08.002","article-title":"Cisplatin-induced ototoxicity: updates on molecular targets","volume":"25","author":"Gentilin","year":"2019","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.apsb.2021.07.002_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/nu10040522","article-title":"Astaxanthin in skin health, repair, and disease: a comprehensive review","volume":"10","author":"Davinelli","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.apsb.2021.07.002_bib16","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3390\/md12010128","article-title":"Astaxanthin: sources, extraction, stability, biological activities and its commercial applications\u2014a review","volume":"12","author":"Ambati","year":"2014","journal-title":"Mar Drugs"},{"key":"10.1016\/j.apsb.2021.07.002_bib17","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1021\/np050354+","article-title":"Astaxanthin, a carotenoid with potential in human health and nutrition","volume":"69","author":"Hussein","year":"2006","journal-title":"J Nat Prod"},{"key":"10.1016\/j.apsb.2021.07.002_bib18","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jnutbio.2009.01.011","article-title":"Astaxanthin protects mitochondrial redox state and functional integrity against oxidative stress","volume":"21","author":"Wolf","year":"2010","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.apsb.2021.07.002_bib19","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.anl.2017.02.001","article-title":"Protective effect of an astaxanthin nanoemulsion against neomycin-induced hair-cell damage in zebrafish","volume":"45","author":"Takemoto","year":"2018","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.apsb.2021.07.002_bib20","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1177\/0145561319866826","article-title":"Investigation of astaxanthin effect on cisplatin ototoxicity in rats by using otoacoustic emission, total antioxidant capacity, and histopathological methods","volume":"100","author":"Kinal","year":"2019","journal-title":"Ear Nose Throat J"},{"key":"10.1016\/j.apsb.2021.07.002_bib21","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1021\/acs.jafc.7b05493","article-title":"Astaxanthin induces the NRF2\/HO-1 antioxidant pathway in human umbilical vein endothelial cells by generating trace amounts of ROS","volume":"66","author":"Niu","year":"2018","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.apsb.2021.07.002_bib22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12951-020-00600-x","article-title":"Astaxanthin-loaded polymer\u2013lipid hybrid nanoparticles (ATX-LPN): assessment of potential otoprotective effects","volume":"18","author":"Gu","year":"2020","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.apsb.2021.07.002_bib23","doi-asserted-by":"crossref","first-page":"111582","DOI":"10.1016\/j.fct.2020.111582","article-title":"Protective effect of astaxanthin against La2O3 nanoparticles induced neurotoxicity by activating PI3K\/AKT\/NRF2 signaling in mice","volume":"144","author":"Yuan","year":"2020","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.apsb.2021.07.002_bib24","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3390\/diseases4040034","article-title":"The role of the NRF2\/ARE antioxidant system in preventing cardiovascular diseases","volume":"4","author":"Smith","year":"2016","journal-title":"Diseases"},{"key":"10.1016\/j.apsb.2021.07.002_bib25","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.bbamcr.2018.02.010","article-title":"NRF2\u2013KEAP1 signaling in oxidative and reductive stress","volume":"1865","author":"Bellezza","year":"2018","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"10.1016\/j.apsb.2021.07.002_bib26","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1089\/ars.2017.7342","article-title":"Transcriptional regulation by NRF2","volume":"29","author":"Tonelli","year":"2018","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.apsb.2021.07.002_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/9372182","article-title":"Activators and inhibitors of NRF2: a review of their potential for clinical development","volume":"2019","author":"Robledinos-Anton","year":"2019","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.apsb.2021.07.002_bib28","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1038\/emm.2014.112","article-title":"Bucillamine prevents cisplatin-induced ototoxicity through induction of glutathione and antioxidant genes","volume":"47","author":"Kim","year":"2015","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.apsb.2021.07.002_bib29","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00280-015-2716-9","article-title":"Ginkgolide B protects against cisplatin-induced ototoxicity: enhancement of Akt\u2013NRF2\u2013HO-1 signaling and reduction of NADPH oxidase","volume":"75","author":"Ma","year":"2015","journal-title":"Canc Chemother Pharmacol"},{"key":"10.1016\/j.apsb.2021.07.002_bib30","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.gene.2017.09.034","article-title":"Design, virtual screening, molecular docking and molecular dynamics studies of novel urushiol derivatives as potential HDAC2 selective inhibitors","volume":"637","author":"Zhou","year":"2017","journal-title":"Gene"},{"key":"10.1016\/j.apsb.2021.07.002_bib31","doi-asserted-by":"crossref","first-page":"8546","DOI":"10.1021\/cr400046x","article-title":"Computational simulation strategies for analysis of multisubunit RNA polymerases","volume":"113","author":"Wang","year":"2013","journal-title":"Chem Rev"},{"key":"10.1016\/j.apsb.2021.07.002_bib32","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ejmech.2012.03.009","article-title":"A novel series of l-2-benzyloxycarbonylamino-8-(2-pyridyl)-disulfidyloctanoic acid derivatives as histone deacetylase inhibitors: design, synthesis and molecular modeling study","volume":"52","author":"Huang","year":"2012","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.apsb.2021.07.002_bib33","doi-asserted-by":"crossref","first-page":"6125","DOI":"10.3390\/md12126125","article-title":"Astaxanthin activates nuclear factor erythroid-related factor 2 and the antioxidant responsive element (NRF2\u2013ARE) pathway in the brain after subarachnoid hemorrhage in rats and attenuates early brain injury","volume":"12","author":"Wu","year":"2014","journal-title":"Mar Drugs"},{"key":"10.1016\/j.apsb.2021.07.002_bib34","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.phrs.2007.01.012","article-title":"Carotenoids and human health","volume":"55","author":"Rao","year":"2007","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.apsb.2021.07.002_bib35","doi-asserted-by":"crossref","first-page":"W443","DOI":"10.1093\/nar\/gkv315","article-title":"PLIP: fully automated protein\u2013ligand interaction profiler","volume":"43","author":"Salentin","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.apsb.2021.07.002_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077453","article-title":"Molecular dynamic simulation reveals damaging impact of RAC1 F28L mutation in the switch I region","volume":"8","author":"Kumar","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.apsb.2021.07.002_bib37","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.compbiomed.2014.04.022","article-title":"An investigation of molecular dynamics simulation and molecular docking: interaction of citrus flavonoids and bovine beta-lactoglobulin in focus","volume":"51","author":"Sahihi","year":"2014","journal-title":"Comput Biol Med"},{"key":"10.1016\/j.apsb.2021.07.002_bib38","first-page":"1","article-title":"A comparative study of drug delivery methods targeted to the mouse inner ear: bullostomy versus transtympanic injection","volume":"121","author":"Murillo-Cuesta","year":"2017","journal-title":"J Vis Exp"},{"key":"10.1016\/j.apsb.2021.07.002_bib39","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/ijc.23754","article-title":"Impact of antioxidant supplementation on chemotherapeutic toxicity: a systematic review of the evidence from randomized controlled trials","volume":"123","author":"Block","year":"2008","journal-title":"Int J Canc"},{"key":"10.1016\/j.apsb.2021.07.002_bib40","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S2352-4642(19)30115-4","article-title":"Interventions for cisplatin-induced hearing loss in children and adolescents with cancer","volume":"3","author":"Freyer","year":"2019","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.apsb.2021.07.002_bib41","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1080\/0284186X.2018.1433323","article-title":"Hearing loss before and after cisplatin-based chemotherapy in testicular cancer survivors: a longitudinal study","volume":"57","author":"Haugnes","year":"2018","journal-title":"Acta Oncol"},{"key":"10.1016\/j.apsb.2021.07.002_bib42","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.toxlet.2015.06.012","article-title":"An integrated view of cisplatin-induced nephrotoxicity and ototoxicity","volume":"237","author":"Karasawa","year":"2015","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.apsb.2021.07.002_bib43","doi-asserted-by":"crossref","first-page":"42769","DOI":"10.1074\/jbc.M206911200","article-title":"Phosphorylation of NRF2 at Ser-40 by protein kinase C regulates antioxidant response element-mediated transcription","volume":"277","author":"Huang","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2021.07.002_bib44","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1096\/fj.04-2591hyp","article-title":"NRF2, a multi-organ protector?.","volume":"19","author":"Lee","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/j.apsb.2021.07.002_bib45","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.biopha.2018.01.080","article-title":"Forskolin protects against cisplatin-induced ototoxicity by inhibiting apoptosis and ROS production","volume":"99","author":"Guo","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.apsb.2021.07.002_bib46","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ijporl.2016.11.004","article-title":"Peanut sprout extract attenuates cisplatin-induced ototoxicity by induction of the Akt\/NRF2-mediated redox pathway","volume":"92","author":"Youn","year":"2017","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"10.1016\/j.apsb.2021.07.002_bib47","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s12551-016-0244-4","article-title":"The KEAP1\u2013NRF2 pathway: promising therapeutic target to counteract ROS-mediated damage in cancers and neurodegenerative diseases","volume":"9","author":"Deshmukh","year":"2017","journal-title":"Biophys Rev"},{"key":"10.1016\/j.apsb.2021.07.002_bib48","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1021\/acs.biochem.9b00943","article-title":"Interaction energetics and druggability of the protein\u2013protein interaction between Kelch-like ECH-associated protein 1 (keap1) and nuclear factor erythroid 2 like 2 (NRF2)","volume":"59","author":"Zhong","year":"2020","journal-title":"Biochemistry"},{"key":"10.1016\/j.apsb.2021.07.002_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.toxlet.2020.04.005","article-title":"Nrf2 activation protects auditory hair cells from cisplatin-induced ototoxicity independent on mitochondrial ROS production","volume":"331","author":"Zhang","year":"2020","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.apsb.2021.07.002_bib50","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.heares.2009.03.003","article-title":"Ebselen attenuates cisplatin-induced ROS generation through Nrf2 activation in auditory cells","volume":"251","author":"Kim","year":"2009","journal-title":"Hear Res"},{"key":"10.1016\/j.apsb.2021.07.002_bib51","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ctrv.2006.09.006","article-title":"Molecular mechanisms of resistance and toxicity associated with platinating agents","volume":"33","author":"Rabik","year":"2007","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.apsb.2021.07.002_bib52","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1055\/s-0039-1684048","article-title":"Mechanisms of cisplatin-induced ototoxicity and prevention","volume":"40","author":"Rybak","year":"2019","journal-title":"Semin Hear"},{"key":"10.1016\/j.apsb.2021.07.002_bib53","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1385\/MN:24:1-3:131","article-title":"Caspase-dependent apoptotic pathways in CNS injury","volume":"24","author":"Yakovlev","year":"2001","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.apsb.2021.07.002_bib54","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0378-5955(03)00142-4","article-title":"Cisplatin ototoxicity in the Guinea pig: vestibular and cochlear damage","volume":"182","author":"Sergi","year":"2003","journal-title":"Hear Res"},{"key":"10.1016\/j.apsb.2021.07.002_bib55","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1038\/sj.cdd.4401863","article-title":"Flunarizine induces NRF2-mediated transcriptional activation of heme oxygenase-1 in protection of auditory cells from cisplatin","volume":"13","author":"So","year":"2006","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.apsb.2021.07.002_bib56","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s10162-008-0126-y","article-title":"Evidence that cisplatin-induced auditory damage is attenuated by downregulation of pro-inflammatory cytokines via NRF2\/HO-1","volume":"9","author":"So","year":"2008","journal-title":"J Assoc Res Otolaryngol"},{"key":"10.1016\/j.apsb.2021.07.002_bib57","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.246","article-title":"MiR-182-5p protects inner ear hair cells from cisplatin-induced apoptosis by inhibiting FOXO3a","volume":"7","author":"Li","year":"2016","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.apsb.2021.07.002_bib58","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.314","article-title":"Epigallocatechin-3-gallate, a prototypic chemopreventative agent for protection against cisplatin-based ototoxicity","volume":"8","author":"Borse","year":"2017","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.apsb.2021.07.002_bib59","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.heares.2019.02.006","article-title":"An optimized, clinically relevant mouse model of cisplatin-induced ototoxicity","volume":"375","author":"Fernandez","year":"2019","journal-title":"Hear Res"},{"key":"10.1016\/j.apsb.2021.07.002_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-12073-0","article-title":"GSTA4 mediates reduction of cisplatin ototoxicity in female mice","volume":"10","author":"Park","year":"2019","journal-title":"Nat Commun"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383521002513?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383521002513?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T16:53:34Z","timestamp":1761929614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383521002513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S2211383521002513"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2021.07.002","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Astaxanthine attenuates cisplatin ototoxicity in\u00a0vitro and protects against cisplatin-induced hearing loss in\u00a0vivo","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2021.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}